Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
111-in-aby-025 (1 trial)
68ga aby-025 (1 trial)
Breast Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (2 total)